Basics Abeona Therapeutics Inc. Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. IPO Date: November 9, 1984 Sector: Healthcare Industry: Biotech Market Cap: $280.49M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 3.57% Avg Daily Range (30 D): $0.12 | 2.01% Avg Daily Range (90 D): $0.12 | 1.96% Institutional Daily Volume Avg Daily Volume: .75M Avg Daily Volume (30 D): 1M Avg Daily Volume (90 D): .78M Trade Size Avg Trade Size (Sh.): 214 Avg Trade Size (Sh.) (30 D): 114 Avg Trade Size (Sh.) (90 D): 101 Institutional Trades Total Inst.Trades: 395 Avg Inst. Trade: $1.43M Avg Inst. Trade (30 D): $.7M Avg Inst. Trade (90 D): $2.22M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.76M Avg Closing Trade (30 D): $.7M Avg Closing Trade (90 D): $2.56M Avg Closing Volume: 45.31K     News Sep 2, 2025 @ 8:59 AM Trends & Growth Strategies in the $13.5 Billion Ca... Source: Researchandmarkets.Com Aug 12, 2025 @ 2:00 PM AscellaHealth Ranks No. 535 on the 2025 Inc. 5000 ... Source: Dea Belazi May 14, 2025 @ 5:57 PM US FDA Orphan Drug Rare Disease Market Clinical Tr... Source: Kuick Research Apr 29, 2025 @ 10:00 AM U.S. FDA Approves ZEVASKYNâ„¢ (prademagene zam... Source: Abeona Therapeutics Inc. Feb 21, 2025 @ 6:00 PM Cell and Gene Therapies in Rare Disorders Market t... Source: Delveinsight Financials   TTM Q1 2025 Q4 2024 Basic EPS $2.07 $-.24 $-.14 Diluted EPS $1.71 $-.24 $-.14 Revenue $ .4M $ M $ M Gross Profit $ $ $ Net Income / Loss $ 108.83M $ -12.03M $ -9.29M Operating Income / Loss $ -22.79M $ -19.73M $ -16.67M Cost of Revenue $ $ $ Net Cash Flow $ 147.6M $ -7.42M $ 7.63M PE Ratio 0.00     Splits Jul 05, 2022:   1:25 Oct 24, 2014:   1:50 Jun 05, 2006:   1:5